• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL1500119 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(13) New Drug Application 2016-03-11 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd Certificate Issued 2017-12-21 view
CXSL2000002 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白注射液 Injection Biological Products(13) New Drug Application 2020-01-08 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd In Review 2020-01-07 view
CXSL1900034 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 Lyophilized Biological Products(1) New Drug Application 2019-04-19 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd In Review 2019-04-18 view
CXSL2000185 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 Lyophilized Biological Products(1) New Drug Application 2020-07-04 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd In Review 2020-07-02 view
CXSL1900031 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 Lyophilized Biological Products(1) New Drug Application 2019-04-01 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd In Review 2019-03-29 view
CXSL2000184 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 Lyophilized Biological Products(1) New Drug Application 2020-07-01 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd In Review 2020-06-29 view
CXSL1900015 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 Lyophilized Biological Products(1) New Drug Application 2019-02-22 四川三叶草生物制药有限公司 Sichuan Clover Biopharmaceuticals Co Ltd In Review 2019-02-21 view
CXSL2101289 阿柏西普眼内注射溶液 aflibercept Injection Biological Products(3.3) New Drug Application 2021-08-27 Sichuan Clover Biopharmaceuticals Co Ltd view
CXSL2101370 重组人Ⅱ型肿瘤坏死因子受体-Fc-血小板生成素拟肽融合蛋白注射液 SCB-219 Injection Biological Products(1) New Drug Application 2021-10-19 Sichuan Clover Biopharmaceuticals Co Ltd view
CXSB2101038 注射用重组人肿瘤坏死因子相关凋亡诱导配体–三聚体融合蛋白 Lyophilized Biological Products(1) Supplementary Application 2021-09-02 Sichuan Clover Biopharmaceuticals Co Ltd view